Using creative co-design to develop a decision support tool for people with malignant pleural effusion.
Co-production
Complex intervention development
Creative co-design
Decision support tool
Malignant pleural effusion
Journal
BMC medical informatics and decision making
ISSN: 1472-6947
Titre abrégé: BMC Med Inform Decis Mak
Pays: England
ID NLM: 101088682
Informations de publication
Date de publication:
05 08 2020
05 08 2020
Historique:
received:
17
05
2019
accepted:
23
07
2020
entrez:
8
8
2020
pubmed:
8
8
2020
medline:
24
11
2020
Statut:
epublish
Résumé
Malignant pleural effusion (MPE) is a common, serious problem predominantly seen in metastatic lung and breast cancer and malignant pleural mesothelioma. Recurrence of malignant pleural effusion is common, and symptoms significantly impair people's daily lives. Numerous treatment options exist, yet choosing the most suitable depends on many factors and making decisions can be challenging in pressured, time-sensitive clinical environments. Clinicians identified a need to develop a decision support tool. This paper reports the process of co-producing an initial prototype tool. Creative co-design methods were used. Three pleural teams from three disparate clinical sites in the UK were involved. To overcome the geographical distance between sites and the ill-health of service users, novel distributed methods of creative co-design were used. Local workshops were designed and structured, including video clips of activities. These were run on each site with clinicians, patients and carers. A joint national workshop was then conducted with representatives from all stakeholder groups to consider the findings and outputs from local meetings. The design team worked with participants to develop outputs, including patient timelines and personas. These were used as the basis to develop and test prototype ideas. Key messages from the workshops informed prototype development. These messages were as follows. Understanding and managing the pleural effusion was the priority for patients, not their overall cancer journey. Preferred methods for receiving information were varied but visual and graphic approaches were favoured. The main influences on people's decisions about their MPE treatment were personal aspects of their lives, for example, how active they are, what support they have at home. The findings informed the development of a first prototype/service visualisation (a video representing a web-based support tool) to help people identify personal priorities and to guide shared treatment decisions. The creative design methods and distributed model used in this project overcame many of the barriers to traditional co-production methods such as power, language and time. They allowed specialist pleural teams and service users to work together to create a patient-facing decision support tool owned by those who will use it and ready for implementation and evaluation.
Sections du résumé
BACKGROUND
Malignant pleural effusion (MPE) is a common, serious problem predominantly seen in metastatic lung and breast cancer and malignant pleural mesothelioma. Recurrence of malignant pleural effusion is common, and symptoms significantly impair people's daily lives. Numerous treatment options exist, yet choosing the most suitable depends on many factors and making decisions can be challenging in pressured, time-sensitive clinical environments. Clinicians identified a need to develop a decision support tool. This paper reports the process of co-producing an initial prototype tool.
METHODS
Creative co-design methods were used. Three pleural teams from three disparate clinical sites in the UK were involved. To overcome the geographical distance between sites and the ill-health of service users, novel distributed methods of creative co-design were used. Local workshops were designed and structured, including video clips of activities. These were run on each site with clinicians, patients and carers. A joint national workshop was then conducted with representatives from all stakeholder groups to consider the findings and outputs from local meetings. The design team worked with participants to develop outputs, including patient timelines and personas. These were used as the basis to develop and test prototype ideas.
RESULTS
Key messages from the workshops informed prototype development. These messages were as follows. Understanding and managing the pleural effusion was the priority for patients, not their overall cancer journey. Preferred methods for receiving information were varied but visual and graphic approaches were favoured. The main influences on people's decisions about their MPE treatment were personal aspects of their lives, for example, how active they are, what support they have at home. The findings informed the development of a first prototype/service visualisation (a video representing a web-based support tool) to help people identify personal priorities and to guide shared treatment decisions.
CONCLUSION
The creative design methods and distributed model used in this project overcame many of the barriers to traditional co-production methods such as power, language and time. They allowed specialist pleural teams and service users to work together to create a patient-facing decision support tool owned by those who will use it and ready for implementation and evaluation.
Identifiants
pubmed: 32758243
doi: 10.1186/s12911-020-01200-3
pii: 10.1186/s12911-020-01200-3
pmc: PMC7404910
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
179Références
JAMA. 2012 Jun 13;307(22):2383-9
pubmed: 22610520
Milbank Q. 2016 Jun;94(2):392-429
pubmed: 27265562
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Int J Health Policy Manag. 2016 Jan 28;5(4):221-3
pubmed: 27239867
Pilot Feasibility Stud. 2019 Mar 12;5:41
pubmed: 30923626
Fam Pract. 2008 Dec;25 Suppl 1:i20-4
pubmed: 18794201
Chest. 2005 Mar;127(3):909-15
pubmed: 15764775
Thorax. 2010 Aug;65 Suppl 2:ii61-76
pubmed: 20696688
BMC Health Serv Res. 2018 Jul 25;18(1):585
pubmed: 30045726
Int J Health Policy Manag. 2016 Oct 17;6(6):345-348
pubmed: 28812827
J Epidemiol Community Health. 2017 Jun;71(6):619-623
pubmed: 28298415
Patient Educ Couns. 2011 Feb;82(2):260-5
pubmed: 20627644
BMC Med. 2018 Jun 20;16(1):92
pubmed: 29921274
BMJ. 2015 Sep 08;351:h4520
pubmed: 26350935
Eur Respir Rev. 2016 Jun;25(140):189-98
pubmed: 27246596